Same-Day Discharge following Holmium Laser Enucleation in Patients Assessed to Have Large Gland Prostates (≥175 cc)

Mark A. Assmus*, Tim Large, Matthew S. Lee, Deepak K. Agarwal, Marcelino E. Rivera, Amy E. Krambeck

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Holmium laser enucleation of the prostate (HoLEP) is a highly effective and durable minimally invasive surgery for benign prostatic hyperplasia. Historically, alternative treatments for large glands (≥175 cc) are associated with prolonged length of stay (LOS) and postoperative catheterization. However, advances in laser technology combined with surgical technique optimization have early evidence supporting same-day discharge. We look to examine contemporary same-day discharge outcomes for large glands. Materials and Methods: With Institutional Review Board (IRB) approval we queried our electronic medical record and retrospective clinical registry to examine perioperative outcomes of large gland (≥175 cc) prostates that underwent HoLEP with consideration for same-day discharge. Results: From December 10, 2019 to September 29, 2020 we identified 55 patients with a preoperative prostate size ≥175 cc (39 CT, 12 MRI, 4 transrectal ultrasound), of which 45 were scheduled for same-day discharge and 10 for admission. Mean preoperative prostate size was 229.9 cc (range 175-535 cc) and 36 (65.5%) were in urinary retention. Mean preoperative prostate-specific antigen (PSA) was 8.58 ng/mL, American Urological Association Symptom Score (AUASS) 22.3, and Qmax 8.8 mL/second. At 3 months postoperative follow-up mean AUASS was 6.7, PSA 0.87 ng/mL and Qmax 20.4 mL/second. All comer same-day discharge rate was 70% (38/55). Of patients planned for same-day discharge 38/45 (84%) were effective. Average LOS for all patients was 11.8 hours with catheterization of 21.2 hours. When compared with 2010 published large gland outcomes, our current LOS represents a 220% reduction. Looking specifically at patients planned for same-day discharge, average LOS and catheter duration was 8.8 and 17.0 hours, whereas LOS and catheter duration for patients planned for admission was 25.7 and 39.4 hours, respectively. Conclusions: We report the first outcomes of preoperatively planned same-day discharge for HoLEP in large glands (≥175 cc). A combination of technologic advances and optimization of technique have allowed for a safe adoption of same-day discharge, providing additional advantages over alternative large gland treatments.

Original languageEnglish (US)
Pages (from-to)1386-1392
Number of pages7
JournalJournal of Endourology
Volume35
Issue number9
DOIs
StatePublished - Sep 2021
Externally publishedYes

Keywords

  • HoLEP
  • large gland
  • same-day discharge

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Same-Day Discharge following Holmium Laser Enucleation in Patients Assessed to Have Large Gland Prostates (≥175 cc)'. Together they form a unique fingerprint.

Cite this